ered, because it would not be in keeping with the rule that CD4+ T cells are the only cells that mediate delayed-type hypersensitivity (DTH)' (15, 17, 18) .
The purpose of this paper is to present evidence that CD4+ Ts cells are responsible for the susceptibility of BALB/c mice to L . major infection. It will demonstrate that eliminating CD4+ Ts cells with a single dose of anti-L3T4 mAb releases CD8 + T cells to mediate a protective immune response capable of eliminating Leishmania from the primary lesion, and of preventing the parasite from disseminating to visceral sites.
Materials and Methods
Mice. Male BALB/c and B6 .PLThy-la/Cy (C57BL/6Thy-1 .1) mice, 7-10 wk old, were obtained from the Trudeau Institute Animal Breeding Facility. The mice were reared under barrier-sustained conditions and were shown to be free of common viral pathogens by serological testing (Charles River Technical Services, Wilmington, MA) .
Parasite. Amastigotes of L . major, strain 173 (MHOM/IR/-/73) (19) , were obtained from the footpads of BALB/c mice as previously described (20) . Primary subcutaneous infections were initiated by injecting 105 amastigotes in 50 /Al of PBS into the left hind footpad. To follow the development of disease, the size of the cutaneous lesion was determined by measuring the thickness of the foot at regular intervals . The numbers of viable parasites in the primary lesion (hind footpad), liver, and spleen were determined by plating appropriately diluted aliquots of homogenized tissues onto heart-infusion agar (20) . After 5-7 d of incubation at 26°C, the promastigote colonies were counted, and the number of viable parasites (CFU) present in the tissues calculated .
In Vivo Depletion of T Cell Subsets. The hybridoma GK1 .5 (Dr. Frank Fitch, University of Chicago, Chicago, IL) secreting rat IgG2b anti-L3T4 mAb, and hybridomas 30-H12 and TIB-210 (American Type Culture Collection, Rockville, MD) producing IgG2b antiThy-1 .2 and anti-Ly-2 .2 mAb, respectively, were grown as ascites in pristane-primed, irradiated BALB/c mice . The IgG2b content of the ascites fluid was quantified by radial immunodiffusion, and the fluids were stored at -70°C until needed . To deplete T cell subsets in vivo, BALB/c mice were thymectomized at 7 wk of age and infused intravenously 1 wk later with a single 1-mg dose of the appropriate mAb, as previously described (21, 22) . One group of control mice received 1 mg of normal, affinity-purified rat IgG (ICN Immunobiologicals, Lisle, IL) . The extent of T cell depletion was determined 1 wk later, and at 5 wk of infection, by flow cytofluorometric analysis with a FACScan cytofluorometer (Becton Dickinson & Co ., Sunnyvale, CA) . Spleen cells were stained with FITC-conjugated antiThy-1 .2, anti-L3T4, and anti-Ly-2 .2 mAbs (22) , and the results are expressed as the number of CD4' and CD8' T cells per spleen .
Delayed-type Hypersensitivity. The capacity of Leishmania-infected mice to express a DTH response was examined using live amastigotes as the eliciting antigen . 72 h before a scheduled sacrifice, baseline measurements of footpad thickness were made, and 106 amastigotes were implanted in the right hind footpad (contralateral to primary footpad lesion) . At 3, 6, 12, 24, 36, 48 , and 72 h, measurements of footpad thickness were made on individually numbered mice.
Results
Depletion of CD4 + T Cells Alone, or CD4+ plus CD8 + T Cells, Results in a Reduction in the Size of the Lesion that Develops at the Site of Leishmania Inoculation. Fig. 1 shows the effect of an intravenous infusion of mAbs specific for T cell subsets on the development of the cutaneous lesion in the Leishmania-inoculated footpad of BALB/c mice.
It can be seen that an increase in the thickness of the infected footpad was first evi-' Abbreviation used in this paper: DTH, delayed-type hypersensitivity. Development of primary lesions in the footpad of untreated and mAb-treated mice. Thymectomized mice were treated with 1 mg of anti-L3T4 (CD4) mAb, anti-Ly-2-2 (CD8) mAb, both mAbs, or 1 mg of affinity-purified rat IgG (treatment control). 1 wk later, these mice, along with thymectomized untreated controls, were infected in the left hind footpad with 10 5 L. major amastigotes. Lesion size is the difference between the thickness of the inoculated foot and that of the contralateral uninfected foot. Data are expressed as the mean of four to six mice per time point. The SD were always 420% of the mean . dent at 3 wk of infection in all experimental groups . In the control mice, and in mice treated with anti-Ly-2 mAb, footpad size continued to increase until 8 wk of infection, after which the entire foot became necrotic, and no further measurements were possible. In contrast, treatment with either anti-L3T4 mAb alone, or anti-L3T4 plus anti-Ly-2 mAb, prevented the lesion from increasing in"size,~after 5 wk . This result would generally be taken to mean that the infection hadlailled to progress in these last mentioned mice .
That treatment with mAb as described above depleted mice of the appropriate T cell subsets is evidenced by the results of flow cytofluorometric analysis of spleen cells shown in Table I . It can be seen that at 5 wk of infection, the absolute numbers of CD4+ and CD8+ T cells in mAb-treated mice were <90% of normal . Residual   TABLE I Numbers of CD4+ and CD8+ Spleen Cells Present in mAb-treated BALBlc Mice at 5 wk of Leishmania major Infection BALB/c mice were thymectomized at 7 wk of age and treated 1 wk later with 1 mg of the appropriate mAb. Groups of mice were infected 1 wk after treatment, and their pooled spleens were analyzed 5 wk later. Absolute numbers were calculated from the percentages obtained from flow cytofluorometric analysis of spleen cells stained with FITC-conjugated anti-Thjy-1 .2, anti=L3T4 (CD4), and anti-Ly-2 (CD8) mAb. The numbers have not been corrected for background . Therefore, they represent the maximum number present in the organ. The background staining with anti-Thy-1 .2 on spleen cells from B6 .Thy-1 .1 mice was 2% . (Table II) revealed that mice depleted of CD4+ T cells were able to prevent the parasite from multiplying progressively at the primary site of infection. At 5 wk, the footpad of anti-L3T4 mAb-treated mice had <1% of the number of parasites found in the footpad of untreated control mice . In fact, by 10 wk, the parasites had been completely eliminated from the primary lesion, and the small number ofLeishmania that had disseminated to the liver had been destroyed .
However, the situation in mice treated with anti-L3T4 plus anti-Ly-2 mAbs was entirely different. In spite of the fact that the primary lesions of mice depleted of both subsets ofT cells were small, these mice proved to have progressive disease. At 5 wk of infection their cutaneous lesions contained up to 10$ viable parasites, and by the ninth week, they began to die of systemic disease. These results show, therefore, that treatment with anti-Ly-2 mAb completely negated the therapeutic effect of treatment with anti-L3T4 mAb. It follows, therefore, that CD8+ T cells are essential for a successful protective immune response against Leuhmanta in BALB/c mice.
BALB/c Mice Depleted Only of CD4' T Cells Acquire a Sustained Capacity to Express a Cutaneous DTH Response to Leishmania Antigens. At 5 and 10 wk of the Leishmania infection, control and mAb-treated mice were tested for their capacity to express a DTH response to Letshmania amastigotes implanted in the foot contralateral to that containing the primary lesion . The criterion for a positive DTH was an increase (CD4') T cells, Ly-2' (CD8') T cells, or both T cell subpopulations. Thymectomized mice were treated with 1 mg of anti-L3T4 mAb, anti-Ly-2 mAb, both mAbs, or 1 mg of affinity-purified rat IgG (treatment control) . 1 wk later, these mice, along with thymectomized untreated controls were infected in the left hind footpad with 105 L. major amastigotes . To elicit DTH, after taking baseline measurements of the right hind footpad (contralateral to primary lesion) of four to six mice from each treatment group, 106 amastigotes were implanted in that site . Data are expressed as footpad swelling (0 .1 mm), i.e., the increase in the thickness of the inoculated foot at the stated times after challenge.
Thymectomized BALB/c mice were treated with 1 mg of appropriate mAb(s) and infected in the hind footpad with 10 5 L. major amastigotes 1 wk later. Data are expressed as the mean ( t SD) increase in thickness (0 .1 mm) of the footpads of four to six mice at 24 h after injection of 10 6 L. major amastigotes.
' Mice in this group had died of systemic disease by 10 wk .
in footpad swelling, which reached a maximum at 24 h, and declined to baseline by 72 h. The time courses of the DTH responses are shown in Fig. 2 , where it can be seen that all mice, except those depleted of both CD4+ and CD8+ T cells, were capable ofexpressing a delayed inflammatory response at 5 wk of infection. Importantly, the largest response was expressed by CD4+ T cell-depleted mice. Furthermore, CD4+ T cell-depleted mice were capable of expressing DTH at 10 wk of infection (Table III) , whereas the capacity ofthe other groups to express a DTH response had waned. These results therefore show that eliminating CD4+ T cells not only allows CD8+ T cells to mediate protective immunity, but that acquisition of CD8+ T cell-mediated protective immunity correlates with the sustained capacity of the mice to express a DTH response to amastigote antigens . Discussion This paper confirms the results ofothers (13) by showing that treatment ofLeishmaniasusceptible BALB/c mice with anti-L3T4 mAb converts them to resistant mice capable of eliminating Leishmania from the site of primary infection and of preventing the dissemination of the parasite to the viscera. This effect of anti-L3T4 mAb treatment is somewhat paradoxical, considering the generally held view that CD4+ T cells are responsible for mediating antiLeishmania immunity by way of their ability to activate the antimicrobial capacity of macrophages via the secretion of lymphokines (4). Indeed, in order to conform to this view, some (12, 15) have attempted to explain the therapeutic effect ofanti-L3T4 mAb treatment by suggesting that immunity is mediated by CD4+ T cells that survive mAb treatment. However, the recent results of Titus et al. (16) challenge the belief that antiLeishmania immunity resides exclusively within the CD4+ T cell subpopulation. These workers found that anti-Ly-2 mAb treatment can exacerbate disease in susceptible BALB/c mice, and also delay, to a certain extent, healing of lesions in the genetically resistant CBA host . The results presented here clearly show that the CD8+ T cell subset is essential for antiLeishmania immunity. They show that the parasite multiplies progressively in anti-Ly-2 mAb-treated mice, and in mice treated with anti-Ly-2 plus anti-L3T4 mAb. In contrast, mice treated with the anti-L3T4 mAb alone acquired the ability to control Leishmania multiplication and to eliminate the parasite in <10 wk. Therefore, there can be little doubt that CD8+ T cells are key protective cells, and that CD8+ T cells can perform their protective role in the virtual absence of the CD4+ T cell subset. This central role for CD8+ T cells in immunity is in agreement with the interpretation of a published (23) immunohistochemical study ofLeishmania-induced granulomas in the livers of BALB/c mice . This published study shows that CD8+ T cells predominate at a time when the parasite is being eliminated from foci of infection.
As to the reason why CD4+ T cells need to be eliminated in order for CD8+ T cells to perform their protective function, the results presented do not support the view that BALB/c mice normally generate too many Leishmania-sensitized CD4+ T cells and, consequently, express disease-promoting levels of DTH (6, 7). The notion that DTH-mediated accumulation of too many mononuclear phagocytes at the site of infection provides Leishmania with cells for it to enter and multiply in is difficult to reconcile with the evidence that mononuclear phagocytes are the cells that are eventually responsible for destroying the parasite. The results presented here indicate that DTH, per se, is not a disease-promoting mechanism. On the one hand, susceptible BALB/c mice not depleted of CD4+ T cells actually had a reduced capacity to express DTH. On the other hand, depletion of CD4+ T cells allowed mice to generate higher levels ofDTH. Moreover, the acquisition of DTH was associated with the generation of an immune response that prevented rather than promoted the multiplication of the parasite.
A key finding from this study is that both DTH and protective immunity to Leishmania are mediated by CD8+ T cells. Both mechanisms were expressed in the virtual absence of CD4+ T cells, but not in the absence of CD8 + T cells. Even so, these results do not rule out a possible role for CD4+ T cells in the DTH response to Leishmania . Indeed, mice treated with the anti-Ly-2 mAb alone also acquired a shortlived capacity to mount a response to an intrafootpad injection ofLeishmania amastigotes. It has been suggested, however, that this inflammatory reaction in susceptible BALB/c mice may not be a true DTH reaction (24) . Until this possibility is investigated, the results can be interpreted to mean that CD8 + as well as CD4+ T cells can mediate DTH in Leishmania-infected BALB/c mice .
Given what is currently known about the response of BALB/c mice to Leishmania infection, the most plausible explanation for the impressive therapeutic effect of anti-L3T4 mAb treatment is that the mAb eliminates CD4' Ts cells, thereby releasing Leishmania-sensitized CD8' T cells to mediate protective immunity. It is apparent that there has been a reluctance to invoke Ts cells to explain the effect of anti-L3T4 mAb treatment, in spite ofthe fact that there are several publications (25) (26) (27) showing that Leishmania-infected mice generate CD4' T cells capable, on passive transfer, of suppressing antiLeishmania immunity in BALB/c mice. It should be pointed out, moreover, that CD4' T cells have been shown to mediate unresponsiveness to a number ofantigens (28) (29) (30) (31) . In this regard, the results presented here are strikingly similar to those recently obtained from a study ofthe effect of deleting T cell subsets on the growth of an immunogenic tumor. It was shown (22) that deleting CD4' T cells resulted in complete regression of the tumor and in long-term host survival. In contrast, deleting CD8' T cells resulted in enhanced tumor growth and in shorter host survival time.
The last finding deserving of discussion is that the size of the primary lesion need not be a reflection of the parasite load in the primary lesion, nor of the severity of systemic disease. On the contrary, the results show that the largest numbers ofLeishmania were present in some of the smallest lesions, namely, in the footpads of mice depleted of both T cell subsets. Thus, the increased thickness of an infected footpad does not represent the space occupied by parasites. Rather, it probably represents mostly edema caused by the host's inflammatory response. It is possible, therefore, that much of the past confusion about both the nature of underlying antiLeishmania immunity in the susceptible host, and the mechanism that suppresses it, has been caused by too heavy a reliance on lesion size measurements to monitor the progress of infection. The current studies serve to emphasize that the only acceptable way to determine the disease status of the host at any one time is to enumerate the parasites in the primary lesion and elsewhere. Summary This study examined the capacity of BALB/c mice that had been depleted of T cell subpopulations to generate a protective immune response to Leishmania major. Thymectomized mice were depleted of either L3T4' (CD4') T lymphocytes, Ly-2' (CD8') T lymphocytes, or both, by treatment with appropriate mAbs . It was found that susceptible mice were rendered resistant to Leishmania by an intravenous infusion of anti-L3T4 mAb. These mice generated an immune response that destroyed the parasite in the primary lesion and in visceral metastatic foci. CD4' cell-depleted mice also acquired a capacity to mount a sustained delayed-type hypersensitivity (DTH) response to parasite antigens, indicating that DTH, per se, is not a disease-promoting mechanism in the susceptible murine host as has been suggested. Depleting BALB/c mice of CD8', as well as CD4' T cells, left them highly susceptible to Leishmania infection, thereby indicating that CD8' lymphocytes are key protective cells. Our results can be interpreted as showing that the susceptibility of BALB/c mice is due to the generation of CD4' cells that suppress either the generation or expression of CD8' T cell-mediated antiLeishmania immunity.
